SCHEMBL20041844

SCHEMBL20041844

COC(=O)C1C(=O)NC[C@@H]1c1cccc(OC)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 1/20 0.53
PDE4B Q07343 1/20 0.53
PDE4C Q08493 1/20 0.53
PDE4D Q08499 1/20 0.53
DDB1 Q16531 1/20 0.48
CRBN Q96SW2 1/20 0.48
SLC9A1 P19634 1/20 0.45
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 2/20 0.45
GLA P06280 1/20 0.45
GAA P10253 1/20 0.45
F2RL1 P55085 2/20 0.45
CYP3A4 P08684 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
HTT P42858 1/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16785390 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL29434258 1.00 PDE4A (0.53) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL16785409 0.88 DDB1 (0.49) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL18106605 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL18117707 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL16785489 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL16785350 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL29434235 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL19559436 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DDDB1
SCHEMBL16785349 0.84 KDM4E (0.53) PDE4APDE4BPDE4CPDE4DKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305763-A1 DEUTERATED OR ISOTOPICALLY LABELED UREA DERIVATIVES OR PHARMACOLOGICALLY ACCEPTABLE SALTS THEREOF USEFUL AS FPRL-1 AGONISTS Kyorin Pharmaceutical Co., Ltd. (JP) 2018-04-11 EP disclosed